REGN

Andrew J. Murphy

Known title: EVP ResearchCIK: 0001796226

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Regeneron Gets EU Approval for Libtayo Dosing, UBS Upgrades Stock. Regeneron received a positive recommendation from the EU's CHMP for an updated Libtayo dosing regimen across all approved cancer types. This regulatory progress follows strong earnings and new Phase III data for a treatment for FOP. UBS recently upgraded the stock to Buy and raised its price target to $978, citing the company's potential value.

this person other insiders at REGN

Transaction History

REGN▼ Sell$3.0M
REGN▼ Sell$1.2M
REGN▲ Buy$0
REGN▼ Sell$0
REGN▲ Buy$19.4M
REGN▼ Sell$21.1M
REGN▼ Sell$770K
REGN▼ Sell$387K
REGN▲ Buy$0
REGN▼ Sell$0
REGN▼ Sell$897K
REGN▼ Sell$465K
REGN▼ Sell$206K
REGN▼ Sell$219K
REGN▼ Sell$384K
REGN▼ Sell$1.2M
REGN▼ Sell$63K
REGN▼ Sell$90K
REGN▼ Sell$52K
REGN▼ Sell$170K
REGN▼ Sell$58K
REGN▼ Sell$617K
REGN▼ Sell$338K
REGN▼ Sell$971K
REGN▼ Sell$213K
REGN▼ Sell$227K
REGN▼ Sell$1.1M
REGN▼ Sell$55K
REGN▲ Buy$8.0M
REGN▼ Sell$15.6M
REGN▼ Sell$173K
REGN▼ Sell$423K
REGN▼ Sell$1.1M
REGN▼ Sell$45K
REGN▼ Sell$457K
REGN▼ Sell$491K
REGN▼ Sell$190K
REGN▼ Sell$16K
REGN▼ Sell$521K
REGN▼ Sell$549K
REGN▼ Sell$699K
REGN▼ Sell$831K
REGN▼ Sell$963
REGN▼ Sell$75K
REGN▼ Sell$13.8M
REGN▲ Buy$8.0M
REGN▼ Sell$6.6M
REGN▼ Sell$4.3M
REGN▼ Sell$565K
REGN▼ Sell$745K
REGN▲ Buy$0
REGN▼ Sell$84K
REGN▼ Sell$47K
REGN▼ Sell$302K
REGN▼ Sell$136K
REGN▼ Sell$110K
REGN▼ Sell$126K
REGN▼ Sell$677K
REGN▼ Sell$1.5M
REGN▼ Sell$1.1M
REGN▼ Sell$797K
REGN▼ Sell$283K
REGN▼ Sell$151K
REGN▲ Buy$5.4M
REGN▼ Sell$11.0M
REGN▼ Sell$15K
REGN▼ Sell$598K
REGN▼ Sell$265K
REGN▼ Sell$279K
REGN▼ Sell$15K
REGN▼ Sell$276K
REGN▼ Sell$163K
REGN▼ Sell$1.3M
REGN▼ Sell$1.3M
REGN▼ Sell$306K
REGN▼ Sell$703K
REGN▲ Buy$5.4M
REGN▼ Sell$10.7M
REGN▼ Sell$0
REGN▲ Buy$0
REGN▼ Sell$371K
REGN▼ Sell$16K
REGN▼ Sell$74K
REGN▼ Sell$7K
REGN▼ Sell$57K
REGN▼ Sell$47K
REGN▼ Sell$49K
REGN▼ Sell$1K
REGN▼ Sell$15K
REGN▼ Sell$78K
REGN▼ Sell$242K
REGN▼ Sell$2K
REGN▼ Sell$214K
REGN▼ Sell$196K
REGN▼ Sell$41K
REGN▼ Sell$161K
REGN▼ Sell$242K
REGN▼ Sell$263K
REGN▼ Sell$380K
REGN▼ Sell$230K
REGN▼ Sell$389K
REGN▼ Sell$0
REGN▲ Buy$1.8M
REGN▼ Sell$4.7M
REGN▼ Sell$214K
REGN▼ Sell$210K
REGN▼ Sell$49K
REGN▼ Sell$95K
REGN▼ Sell$77K
REGN▼ Sell$344K
REGN▼ Sell$60K
REGN▼ Sell$211K
REGN▼ Sell$454K
REGN▼ Sell$497K
REGN▼ Sell$56K
REGN▼ Sell$4.1M
REGN▲ Buy$1.8M
REGN▼ Sell$120K
REGN▼ Sell$103K
REGN▼ Sell$102K
REGN▼ Sell$38K
REGN▼ Sell$39K
REGN▼ Sell$38K
REGN▼ Sell$39K
REGN▼ Sell$81K
REGN▼ Sell$51K
REGN▼ Sell$308K
REGN▼ Sell$516K
REGN▼ Sell$313K
REGN▼ Sell$284K
REGN▼ Sell$84K
REGN▼ Sell$235K
REGN▲ Buy$1.8M
REGN▼ Sell$4.2M
REGN▼ Sell$274K
REGN▼ Sell$183K
REGN▼ Sell$327K
REGN▼ Sell$62K
REGN▼ Sell$139K
REGN▼ Sell$101K
REGN▼ Sell$117K
REGN▼ Sell$31K
REGN▼ Sell$264K
REGN▼ Sell$335K
REGN▼ Sell$395K
REGN▼ Sell$4.0M
REGN▲ Buy$1.8M
REGN▼ Sell$463K
REGN▼ Sell$244K
REGN▼ Sell$234K
REGN▼ Sell$187K
REGN▼ Sell$3K
REGN▼ Sell$262K
REGN▼ Sell$217K
REGN▼ Sell$181K
REGN▼ Sell$105K
REGN▼ Sell$269K
REGN▼ Sell$256K
REGN▼ Sell$187K
REGN▼ Sell$1.2M
REGN▼ Sell$682K
REGN▼ Sell$585K
REGN▼ Sell$147K
REGN▼ Sell$26K
REGN▲ Buy$858K
REGN▼ Sell$6.2M
REGN▲ Buy$0
REGN▼ Sell$87K
REGN▼ Sell$60K
REGN▼ Sell$49K
REGN▼ Sell$102K
REGN▼ Sell$297K
REGN▼ Sell$130K
REGN▼ Sell$44K
REGN▼ Sell$193K
REGN▼ Sell$546K
REGN▼ Sell$56K
REGN▼ Sell$3K
REGN▼ Sell$299K
REGN▼ Sell$595K
REGN▼ Sell$47K
REGN▼ Sell$713K
REGN▼ Sell$1.1M
REGN▼ Sell$360K
REGN▼ Sell$6.0M
REGN▲ Buy$863K
REGN▼ Sell$0

We use analytics to understand how market-wall is used. No personal data is sold.